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We read with interest the American Diabetes Association
(ADA) and the European Association for the Study of
Diabetes (EASD) joint consensus report on the management
of hyperglycaemia in Type 2 diabetes [1]. Following publi-
cation of the report, discussions of the content among
networks of behavioural and educational researchers
prompted us to write this letter.
This consensus report is to be commended for recom-
mending that ‘providers and health care systems should
prioritize the delivery of patient-centered care’. The report is
also to be commended for providing some clear actions that
can be taken to promote person-centred care, including
emphasizing the importance of diabetes self-management
education and support, promoting shared decision-making
between the person with diabetes and the healthcare profes-
sional, and pointing to some methods that may be beneficial
in achieving this. At the same time, we also appreciate that
there are challenges in implementing a person-centred
approach and we would like to highlight and comment on
some of the challenges we see in the Consensus Report.
The first is that the report uses the term ‘adherence’
throughout, making the recommendation that ‘Facilitating
medication adherence should be specifically considered when
selecting glucose-lowering medications’. Whilst we agree that
it is important to discuss the issues surrounding an individ-
ual’s willingness and ability to take any prescribed medica-
tions, we suggest that the word ‘adherence’ is used ill-
advisedly in the report. A recent series of position statements
from Diabetes Australia [2], jointly by the ADA and
American Association of Diabetes Educators [3] and jointly
by Diabetes UK and the UK’s National Health Service [4],
have pointed to the negative consequences of using the terms
‘adherence’ and ‘compliance’, when talking with or about
people living with diabetes. These position statements echo
earlier commentaries that argue that compliance and adher-
ence are dysfunctional concepts, and empirical work demon-
strating that the assumptions underpinning these words are
not substantiated [5]. The continued use of the term
‘adherence’, which implies an unequal relationship in which
people with diabetes passively follow clinicians’ instructions,
is at best unhelpful. The fact that diabetes care is largely
stuck in this ‘adherence’ paradigm may explain why a series
of Cochrane reviews on interventions to promote adherence
have repeatedly concluded that ‘Current methods of improv-
ing medication adherence for chronic health problems are
mostly complex and not very effective’ [6], and argued that
the problem needs to be reconceptualized. This can be done
readily by active adoption of ‘strengths-based, empowering
language’ [3] and of other recommendations in the above-
mentioned position statements [2–4] to facilitate active
engagement in self-care, health and well-being.
We are also concerned with the statement that ‘effective
consultations include motivational interviewing’. ‘Motiva-
tional interviewing’ is a specific set of intervention strategies
and techniques requiring extensive training and significant
time to deliver. Consequently, it is not possible for most
health professionals to include ‘motivational interviewing’ in
routine clinical and education practice. Furthermore, recom-
mendations for integrating a specific set of tools and
techniques into clinical practice require a high-quality
evidence base; however, this does not exist for motivational
interviewing in diabetes or chronic disease care [7]. Whilst
meta-analyses indicate a possible small benefit of such
interventions, this is conflated with the additional time
investment. We suggest that the emphasis needs to be placed
not on specific methods but on the principles underpinning
‘motivational interviewing’, common to many effective
psycho-educational interventions and essential to effective
diabetes care. These principles move the clinician away from
an ‘adherence’ paradigm, to focus not on persuading the
person with diabetes to take a certain medication, but rather
to raise awareness of the individual’s choices and enable
agreement about which management option best fits the
individual’s needs, goals, values and preferences.
As part of the goal to individualize care, the Consensus
Report also provides guidance on the assessment of ‘key
patient characteristics’; specifically, recommending assess-
ment of ‘issues such as motivation and depression’. This
seems at odds with ADA’s 2016 position statement on the
psychosocial care of people with diabetes, which recom-
mends considering an ‘assessment of symptoms of diabetes
distress, depression, anxiety, and disordered eating and of
cognitive capacities’ [8], and the ADA’s 2019 standards of
diabetes care [9]. Thus, we are surprised that this joint
consensus report does not specifically recommend assessment
of diabetes distress, especially given a recent meta-analysis,
which indicates that about one-third of individuals with
Type 2 diabetes experience clinically significant levels of
diabetes distress [10]. We are also surprised that the report
recommends the assessment of ‘motivation’, given that this
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term is vague, often used inappropriately, and is not easily
assessed. We acknowledge that achieving a paradigm shift
takes time, and requires persistent, consistent and insistent
advocacy. However, it is disappointing that this joint
Consensus Report does not appear to be implementing the
recent recommendations of the ADA, and other international
bodies, to incorporate strengths-based language and related
strategies, with the aim of enabling widespread promotion of
truly person-centred diabetes care. We we would therefore
like to recommend that future similar endeavours (consensus
reports, guidelines, position statements) include representa-
tion of a broader range of disciplines and relevant associa-
tions and study groups, e.g. the American Association of
Diabetes Educators (AADE), the Psycho-Social Aspects of
Diabetes Study (PSAD) group of the EASD, and the US-based
Behavioral Research In Diabetes Group Exchange
(BRIDGE).
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